RxDoctor Payments Data
★ My doctorsLook up a doctor →

Franco Vigna, MD

Orthopaedic Surgery of the Spine · Niagara Falls, NYNPI 1760489736

Payments from drug & device makers

What this record shows

This record is dominated by royalties or licence payments: $211,493 of the $261,280 with a category attached, or 80.9%. Surgalign Spine Technologies, Inc. accounts for 84.7% of it on its own, with 27 other manufacturers making up the rest. Reporting peaked in 2019 at $71,144 and has fallen 79.8% since, to $14,371 in 2025. Among orthopaedic surgery of the spine clinicians in NY with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$261,280in general payments, 2019–2025

Across 417 payments — averaging $626.57 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Surgalign Spine Technologies, Inc.$221K
  • Xtant Medical Inc$32K
  • Abbott$5K
  • Boston Scientific$526
  • Medtronic$309
  • Novapproach Spine, LLC$250
  • plus $1K from 22 others

What the payments were for

  • Royalty or licence$211,49381%
  • Consulting fees$30,05012%
  • Speaking & faculty fees$1500%
  • Travel & lodging$8,7123%
  • Food & beverage$9,2864%
  • Education$1,5701%
  • Gifts$180%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Surgalign Spine Technologies, Inc.114$221,394
Xtant Medical Inc10$32,313
Abbott209$5,231
Boston Scientific24$526
Medtronic(2 entities)7$309
Novapproach Spine, LLC1$250
Nevro Corp.14$216
Si-bone, Inc.9$213
Cerapedics Inc.2$87
Avanos Medical1$84
Johnson & Johnson3$72
Zimmer Biomet1$71
Merck4$62
DJO, LLC2$55
Bioventus LLC2$52
Smith+Nephew2$38
Baxter Healthcare1$32
Ossur Americas, Inc.1$32
Solventum Corporation1$32
Stryker1$30
Organogenesis Inc.1$27
Averitas Pharma Inc.1$27
Curonix LLC1$25
Pacira Pharmaceuticals Incorporated1$24
Coastal Medical Technologies LLC1$22
Amgen1$21
KCI USA, Inc.1$20
Aesculap, Inc.1$15

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$261,280 in reported general payments places this provider in the 90th percentile of 161 orthopaedic surgery of the spine providers in New York.

See all orthopaedic surgery of the spine providers in New York →

Medicare billing

Part B allowed, 2024
$99,744
Medicare patients
104
Services billed
571

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen16$212

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery of the spine in Niagara Falls

See the full list for New York →

Where these figures come from

Is this you, or does something look wrong? →